APA (7th ed.) Citation

Selvaraj, M., Mahapatra, M., & Parida, S. (2021). Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR. MDPI AG.

Chicago Style (17th ed.) Citation

Selvaraj, Muneeswaran, Mana Mahapatra, and Satya Parida. Exchange of C-Terminal Variable Sequences Within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) Against PPR. MDPI AG, 2021.

MLA (8th ed.) Citation

Selvaraj, Muneeswaran, et al. Exchange of C-Terminal Variable Sequences Within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) Against PPR. MDPI AG, 2021.